Enanta Pharmaceuticals (ENTA) Revenue (2012 - 2026)
Enanta Pharmaceuticals' Revenue was $14.36 million in fiscal Q3 2026 (quarter ended Jun 30, 2026), down 21.6% from $18.31 million a year earlier and down 16.3% from the prior quarter.
Powered by 
Analysis
Enanta Pharmaceuticals (ENTA) Revenue (2012 - 2026) Analysis & Trends
On a trailing twelve-month basis, Enanta Pharmaceuticals' Revenue was $65.26 million through Jun 30, 2026, up 0.7% year-over-year; for FY2025 (ended Sep 30, 2025), it was $65.32 million, down 3.4% from FY2024.
- Revenue has now declined for seven consecutive fiscal years, with a five-year compound annual growth rate of -11.8% (FY2020 to FY2025).
- In earlier fiscal years, Revenue was $67.64 million in FY2024 (-14.6%), $79.2 million in FY2023 (-8.1%), $86.16 million in FY2022 (-11.2%) and $97.07 million in FY2021 (-20.7%).
- The fiscal Q3 2026 figure marks the lowest quarterly Revenue since fiscal Q3 2017.
- Compared with a year earlier, Revenue was higher in four of the last eight quarters, with an average decline of 4.1%.
- The best year-over-year quarter for Revenue over five years was fiscal Q2 2026 (growth of 15.0%); the worst was fiscal Q1 2024 (a decline of 23.7%).
- Per Business Quant data, ENTA's Revenue in the three fiscal quarters before Q3 2026 was $17.16 million (Q2 2026), $18.62 million (Q1 2026) and $15.13 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 15.38 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 10.05 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 7.80 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 15.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 3.33 Bn |
| 10 | Enanta Pharmaceuticals | 367.20 Mn | -360.79 Mn | - | 14.36 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.36 Mn |
| Mar 31, 2026 | 17.16 Mn |
| Dec 31, 2025 | 18.62 Mn |
| Sep 30, 2025 | 15.13 Mn |
| Jun 30, 2025 | 18.31 Mn |
| Mar 31, 2025 | 14.93 Mn |
| Dec 31, 2024 | 16.96 Mn |
| Sep 30, 2024 | 14.61 Mn |
| Jun 30, 2024 | 17.97 Mn |
| Mar 31, 2024 | 17.05 Mn |
| Dec 31, 2023 | 18.00 Mn |
| Sep 30, 2023 | 18.93 Mn |
| Jun 30, 2023 | 18.89 Mn |
| Mar 31, 2023 | 17.80 Mn |
| Dec 31, 2022 | 23.59 Mn |
| Sep 30, 2022 | 20.32 Mn |
| Jun 30, 2022 | 19.48 Mn |
| Mar 31, 2022 | 18.72 Mn |
| Dec 31, 2021 | 27.65 Mn |
| Sep 30, 2021 | 23.58 Mn |
API Access
Enanta Pharmaceuticals Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=ENTA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "ENTA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=ENTA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();